Clinical Conductor CTMS’s parent company, Bio-Optronics, and the Society of Clinical Research Sites (SCRS) have partnered to expand and advance the knowledge of clinical trial site management challenges and opportunities. Clinical Conductor CTMS and the SCRS have identified critical metrics with the goal of establishing industry benchmarks for clinical research sites.
 
Clinical Conductor CTMS has provided non-patient information from sites that have agreed to participate. These metrics will assist SCRS in establishing site metrics and cycle times for a number of clinical trial parameters, including study startup cycle time, patient enrollment metrics, budgetary and contract statistics and other analytics.
 
“SCRS is committed to supporting the success of the global clinical site community. Reliable data and metrics provide sites and industry stakeholders with information that will help shape the site landscape,” said Christine Pierre, president of SCRS. “The collaboration during these early stages has been instrumental in helping us achieve this goal. Their willingness to collaborate with SCRS and to build SCRS’ Site Metrics Platform to allow all sites to contribute their data moving forward is a testimonial to the collaborative efforts SCRS values.”
 
“The advancement of clinical trial management and research operations is one of the guiding principles behind Clinical Conductor CTMS,” said Dan Kerpelman, chief executive officer of Bio-Optronics. “Working with the SCRS to establish actionable metrics for the benefit of all researchers was a natural initiative for our organization. We take pride in our ability to participate in this noteworthy and beneficial venture.”